These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 23490034)

  • 21. Hepatitis C virus recurrence after liver transplantation: a 10-year evaluation.
    Gitto S; Belli LS; Vukotic R; Lorenzini S; Airoldi A; Cicero AF; Vangeli M; Brodosi L; Panno AM; Di Donato R; Cescon M; Grazi GL; De Carlis L; Pinna AD; Bernardi M; Andreone P
    World J Gastroenterol; 2015 Apr; 21(13):3912-20. PubMed ID: 25852276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors Associated with Increase in Skeletal Muscle Mass after Sustained Virological Response in Chronic Hepatitis C Treated with Direct Acting Antivirals.
    Yoh K; Nishikawa H; Enomoto H; Ishii A; Iwata Y; Miyamoto Y; Ishii N; Yuri Y; Hasegawa K; Nakano C; Nishimura T; Aizawa N; Sakai Y; Ikeda N; Takashima T; Takata R; Iijima H; Nishiguchi S
    Nutrients; 2017 Oct; 9(10):. PubMed ID: 29057827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of pretransplant chronic hepatitis C virus infection treatment on graft and patient survival in renal transplant recipients.
    Korkmaz M; Fakı S; Öcal S; Harmancı Ö; Ensaroğlu F; Selçuk H; Haberal M
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():188-92. PubMed ID: 25894152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of female sex on hepatitis C virus infection progression and treatment outcomes.
    Corsi DJ; Karges W; Thavorn K; Crawley AM; Cooper CL
    Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):405-11. PubMed ID: 26745470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNAs as predictor markers for response to interferon treatment of chronic hepatitis C genotype-4 in Egyptian patients.
    Motawi TM; Rizk SM; Shaker OG; Mokhtar OZ
    PLoS One; 2015; 10(3):e0121524. PubMed ID: 25811198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term outcomes of chronic hepatitis C patients with sustained virological response at 6 months after the end of treatment.
    Chavalitdhamrong D; Tanwandee T
    World J Gastroenterol; 2006 Sep; 12(34):5532-5. PubMed ID: 17006994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferon-Free Therapy in Elderly Patients With Advanced Liver Disease.
    Lens S; Fernández I; Rodríguez-Tajes S; Hontangas V; Vergara M; Forné M; Calleja JL; Diago M; Llaneras J; Llerena S; Torras X; Sacristán B; Roget M; Fernández-Rodríguez CM; Navascués MC; Fuentes J; Sánchez-Ruano JJ; Simón MÁ; Sáez-Royuela F; Baliellas C; Morillas R; Forns X;
    Am J Gastroenterol; 2017 Sep; 112(9):1400-1409. PubMed ID: 28585554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical outcomes in chronic hepatitis C long-term responders to pre-direct antiviral agents: a single-center retrospective study.
    Rosso C; Caviglia GP; Ciruolo M; Ciancio A; Younes R; Olivero A; Giordanino C; Troshina G; Abate ML; Rizzetto M; Pellicano R; Saracco GM; Bugianesi E; Smedile A
    Minerva Med; 2019 Oct; 110(5):401-409. PubMed ID: 31081312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of sustained virological response to chronic hepatitic C antiviral therapy on new onset diabetes mellitus type 2 after controlling for metabolic syndrome.
    Pandya P; Pant C; Taylor R; Oni O
    J Investig Med; 2017 Apr; 65(4):765-771. PubMed ID: 28232517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Worsening of Serum Lipid Profile after Direct Acting Antiviral Treatment.
    Gitto S; Cicero AFG; Loggi E; Giovannini M; Conti F; Grandini E; Guarneri V; Scuteri A; Vitale G; Cursaro C; Borghi C; Andreone P
    Ann Hepatol; 2018; 17(1):64-75. PubMed ID: 29311405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Real-world treatment patterns and clinical outcomes of HCV treatment-naive patients in China: an interim analysis from the CCgenos study.
    Rao HY; Li H; Chen H; Shang J; Xie Q; Gao ZL; Li J; Sun Y; Jiang J; Wang L; Zhao L; Zhang L; Yang W; Niu J; Gong Z; Gong G; Yang R; Lee MH; Wei L
    J Gastroenterol Hepatol; 2017 Jan; 32(1):244-252. PubMed ID: 27289083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toward a more complete understanding of the association between a hepatitis C sustained viral response and cause-specific outcomes.
    Innes HA; McDonald SA; Dillon JF; Allen S; Hayes PC; Goldberg D; Mills PR; Barclay ST; Wilks D; Valerio H; Fox R; Bhattacharyya D; Kennedy N; Morris J; Fraser A; Stanley AJ; Bramley P; Hutchinson SJ
    Hepatology; 2015 Aug; 62(2):355-64. PubMed ID: 25716707
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiviral therapy improves overall survival in hepatitis C virus-infected patients who develop diffuse large B-cell lymphoma.
    Hosry J; Mahale P; Turturro F; Miranda RN; Economides MP; Granwehr BP; Torres HA
    Int J Cancer; 2016 Dec; 139(11):2519-28. PubMed ID: 27501007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High Risk of Infection During Triple Therapy with First-Generation Protease Inhibitors: A Nationwide Cohort Study.
    Berden FA; van Zwietering IM; Maan R; de Knegt RJ; Kievit W; Drenth JP
    J Gastrointestin Liver Dis; 2016 Jun; 25(2):197-204. PubMed ID: 27308651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Case selection for interferon treatment of hepatitis C.
    Zeniya M; Toda G
    J Gastroenterol Hepatol; 2000 May; 15 Suppl():E117-22. PubMed ID: 10921393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin resistance and sustained virological response in hepatitis C: from bench to bedside.
    Romero-Gómez M
    Liver Int; 2011 Jan; 31(1):1-3. PubMed ID: 21062414
    [No Abstract]   [Full Text] [Related]  

  • 37. Exaggerated immune reactions predict the outcome of interferon therapy in patients with chronic hepatitis C.
    Tarantino G; Conca P; Ariello M; Arena A
    Int J Immunopathol Pharmacol; 2007; 20(4):837-40. PubMed ID: 18179757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Making the best of a bad situation: early chronic nosocomial HCV infection.
    Santos C; Herrine SK
    Dig Dis Sci; 2010 Jun; 55(6):1509-11. PubMed ID: 20480237
    [No Abstract]   [Full Text] [Related]  

  • 39. Hyperlipasemia associated with hepatitis C virus.
    Yoffe B; Bagri AS; Tran T; Dural AT; Shtenberg KM; Khaoustov VI
    Dig Dis Sci; 2003 Aug; 48(8):1648-53. PubMed ID: 12924663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful lung transplantation from a hepatitis C RNA-positive donor to a hepatitis C treatment-experienced recipient with cystic fibrosis.
    Harano T; Haidar G; Schaheen L; Morrell MR; Pilewski JM; D'Cunha J
    J Thorac Cardiovasc Surg; 2019 Oct; 158(4):e155-e157. PubMed ID: 31229293
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.